[Comparative efficacy of infliximab and adalimumab in patients with rheumatoid arthritis]

Autor:	V P, Tiurin, T V, Mezenova, T O, Iutrina, Iu V, Usacheva
Předmět:	Adult Male Adalimumab Antibodies Monoclonal Middle Aged Antibodies Monoclonal Humanized Infliximab Arthritis Rheumatoid Young Adult Treatment Outcome Antirheumatic Agents Humans Female Aged
Zdroj:	Europe PubMed Central
Popis:	We compared the efficacy of recombinant infliximab and adalimumab in patients with severe and moderately severe rheumatoid arthritis. Infliximab produced rapid anti-inflammatory effect in the early period of therapy whereas adalimumab ensured more stable reduction of clinical and laboratory parameters of activity.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0a2d2ee5ad1d842754f1c4624b0e538a http://europepmc.org/abstract/med/24437172 Zobrazit plný text záznamu